|
市場調查報告書
全球HIV治療藥物市場:2010年∼2014年
Global HIV Drugs Market 2010-2014
|
全球HIV治療藥物市場:2010年∼2014年 是由出版商Infiniti Research Limited在2011年12月所出版的。
這份英文市場調查報告書包含Pages: 31 價格從美金1500起跳。
本報告提供全球HIV治療藥物市場相關資料，2010年到2014年分析，市場規模與其預測，市場成長要素和課題，主要供應商分析等資訊，為您概述為以下內容。
第1章 摘要整理
第2章 簡介
第3章 市場範圍
第4章 市場情況
第5章 業者情勢
第6章 購買標準
第7章 市場發展因素
第8章 發展因素與其影響
第9章 市場課題
第10章 市場趨勢
第11章 主要供應商分析
- Gilead Sciences Inc.
- Bristol-Myers Squibb Co.
- Abbott Laboratories
- ViiV Healthcare
第12章 相關報告
圖表
ABSTRACT
TechNavio's analysts forecast the Global HIV Drugs market to reach US$15.5 billion by 2014. One of the key factors contributing to this market growth is the increase in the use of highly active antiretroviral therapy. The Global HIV Drugs market has also been witnessing the need for novel HIV drugs. However, the expiration of patents of key drugs in 2010 could be a challenge to the growth of this market.
TechNavio's report, Global HIV Drugs Market 2010-2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions. It covers the segments such as Hospitals, Patient Diagnostic Centers, and Point-of-Care Centers. The report also analyzes the Global HIV Drugs market landscape and its growth prospects. Further, it includes a discussion of the key vendors operating in this market.
Key vendors dominating this market include Gliead Sciences Inc., Bristol-Myers Squibb Co., Abbott Laboratories, ViiV Healthcare.
Key questions answered in this report:
- What will the market size be in 2014 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
TABLE OF CONTENTS
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
- 11.1 Gilead Sciences Inc.
- 11.2 Bristol-Myers Squibb Co.
- 11.3 Abbott Laboratories
- 11.4 ViiV Healthcare
12. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Global HIV Drugs Market 2010-2014 (US$ billions)
- Exhibit 2: Global HIV Drugs Market by Geographical Segmentation 2010
- Exhibit 3: Patients Suffering from HIV by Geographical Segmentation 2010
- Exhibit 4: Global HIV Drugs Market by Key Customer Segmentation 2010
- Exhibit 5: Global HIV Drugs Market by Key Vendor Segmentation 2010
|
